LAVA Therapeutics NV Basic Shares Outstanding (Weighted Average)
LAVA Therapeutics NV reported Basic Shares Outstanding (Weighted Average) of 26.90 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2025-11-06
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 26.90M shares, a 0.20% increase year-over-year.
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 26.90M shares, a 0.29% increase year-over-year.
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 26.89M shares, a 0.37% increase year-over-year.
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for the quarter ending 2024-12-31 was 26.89M shares.
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for fiscal 2024 was 26.83M shares, a 0.38% increase from fiscal 2023.
- LAVA Therapeutics NV weighted average number of shares outstanding, basic for fiscal 2023 was 26.73M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2025-09-30 | 26.90M shares 10-Q · filed 2025-11-06 | 26.90M shares derived: average of 2 quarters · filed 2025-11-06 | 26.90M shares 10-Q · filed 2025-11-06 | 26.90M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 26.90M shares 10-Q · filed 2025-08-13 | 26.89M shares 10-Q · filed 2025-08-13 | 26.89M shares derived: average of 3 quarters · filed 2025-08-13 | 26.88M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | 26.89M shares 10-Q · filed 2025-05-14 | 26.89M shares derived: average of 2 quarters · filed 2025-05-14 | 26.88M shares derived: average of 3 quarters · filed 2025-11-06 | 26.86M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | 26.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 26.87M shares derived: average of 2 quarters · filed 2025-11-06 | 26.85M shares derived: average of 3 quarters · filed 2025-11-06 | 26.83M shares 10-K · filed 2025-03-28 |
| 2024-09-30 | 26.85M shares 10-Q · filed 2025-11-06 | 26.83M shares derived: average of 2 quarters · filed 2025-11-06 | 26.82M shares 10-Q · filed 2025-11-06 | |
| 2024-06-30 | 26.82M shares 10-Q · filed 2025-08-13 | 26.81M shares 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | 26.79M shares 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 26.73M shares 10-K · filed 2025-03-28 |